Abstract | INTRODUCTION: PATIENTS AND METHODS: We performed immunohistochemical staining to investigate LAMP1 protein expression levels in 122 diffuse large B-cell lymphoma (DLBCL) tumor samples and 45 reactive hyperplasia tissues. Correlations between LAMP1 expression, various clinicopathologic features, and patient prognosis were evaluated by univariate and multivariate analyses. RESULTS: LAMP1 expression was greater in the DLBCL tissues than in the reactive hyperplasia tissues. High LAMP1 expression was significantly associated with a high international prognostic index (score, 3-5; P = .023) and elevated lactate dehydrogenase level (P = .028). Moreover, high LAMP1 expression (P = .026), elevated serum lactate dehydrogenase level (P = .011), and high international prognostic index (P < .001) were independently associated with worse overall survival and progression-free survival. CONCLUSION: These data provide the first evidence that LAMP1 expression is associated with a poor prognosis in patients with DLBCL.
|
Authors | Qingxiu Dang, Hong Zhou, Juan Qian, Li Yang, Jianfei Huang, Yaping Zhang, Wenyu Shi |
Journal | Clinical lymphoma, myeloma & leukemia
(Clin Lymphoma Myeloma Leuk)
Vol. 18
Issue 11
Pg. 749-754
(11 2018)
ISSN: 2152-2669 [Electronic] United States |
PMID | 30082222
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers, Tumor
- LAMP1 protein, human
- Lysosome-Associated Membrane Glycoproteins
|
Topics |
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Biomarkers, Tumor
(metabolism)
- Female
- Follow-Up Studies
- Humans
- Lymphoma, Large B-Cell, Diffuse
(drug therapy, metabolism, pathology)
- Lysosome-Associated Membrane Glycoproteins
(metabolism)
- Male
- Middle Aged
- Prognosis
- Retrospective Studies
- Survival Rate
- Tissue Array Analysis
- Young Adult
|